
Wikitin25 mg
Aristopharma Ltd.
Omarigliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Omarigliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Dosing of Omarigliptin should always be individualized by a physician based on glycemic control, concomitant therapy, and renal function.
| Renal function | Recommended dose |
|---|---|
| Normal to mild renal impairment | 25 mg orally, once weekly |
| Moderate to severe renal impairment / end-stage renal disease (on dialysis) | Reduced dose (e.g. 12.5 mg once weekly) as advised by the treating physician |
If a dose of Omarigliptin is missed, it should be taken as soon as remembered on the same day, provided the next scheduled dose is not due within the next 3 days; otherwise the missed dose should be skipped and the regular weekly schedule resumed. A double dose should never be taken to make up for a missed one.
See Contraindications and Precautions and Warnings for situations requiring caution or avoidance.
Most patients tolerate Omarigliptin well. Reported side effects include:
Patients should seek medical attention promptly if they experience severe abdominal pain, signs of an allergic reaction, severe joint pain, or unusual skin blistering.
Omarigliptin is contraindicated in patients with a known history of hypersensitivity to Omarigliptin or any component of the formulation, and in patients with a history of a serious hypersensitivity reaction (such as angioedema, anaphylaxis, or Stevens-Johnson syndrome) to Omarigliptin or to another DPP-4 inhibitor, given the recognized class effect.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.